Which has better valuation & earnings, MCK or DXCM?

McKesson has higher revenue and earnings than DexCom. McKesson is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio McKesson $403.43B 0.22 $4.76B $38.47 19.18 DexCom $4.82B 5.83 $836.30M $2.34 31.13

Is MCK or DXCM more profitable?

DexCom has a net margin of 19.31% compared to McKesson's net margin of 1.18%. DexCom's return on equity of 33.33% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets McKesson 1.18% -345.35% 5.85% DexCom 19.31% 33.33% 13.19%

Does the media prefer MCK or DXCM?

In the previous week, McKesson had 9 more articles in the media than DexCom. MarketBeat recorded 31 mentions for McKesson and 22 mentions for DexCom. McKesson's average media sentiment score of 1.37 beat DexCom's score of 1.25 indicating that McKesson is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 25 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DexCom 20 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, HQY or MCK?

McKesson has higher revenue and earnings than HealthEquity. McKesson is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HealthEquity $1.31B 5.38 $215.20M $2.67 31.64 McKesson $403.43B 0.22 $4.76B $38.47 19.18

Is HQY or MCK more profitable?

HealthEquity has a net margin of 17.25% compared to McKesson's net margin of 1.18%. HealthEquity's return on equity of 14.75% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets HealthEquity 17.25% 14.75% 9.22% McKesson 1.18% -345.35% 5.85%

Does the media prefer HQY or MCK?

In the previous week, McKesson had 7 more articles in the media than HealthEquity. MarketBeat recorded 31 mentions for McKesson and 24 mentions for HealthEquity. McKesson's average media sentiment score of 1.37 beat HealthEquity's score of 0.59 indicating that McKesson is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 7 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive McKesson 25 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, MCK or HSIC?

McKesson has higher revenue and earnings than Henry Schein. McKesson is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio McKesson $403.43B 0.22 $4.76B $38.47 19.18 Henry Schein $13.18B 0.65 $398M $3.31 22.90

Is MCK or HSIC more profitable?

Henry Schein has a net margin of 2.95% compared to McKesson's net margin of 1.18%. Henry Schein's return on equity of 15.44% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets McKesson 1.18% -345.35% 5.85% Henry Schein 2.95% 15.44% 5.53%

Does the media favor MCK or HSIC?

In the previous week, McKesson had 15 more articles in the media than Henry Schein. MarketBeat recorded 31 mentions for McKesson and 16 mentions for Henry Schein. McKesson's average media sentiment score of 1.37 beat Henry Schein's score of 0.77 indicating that McKesson is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 25 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Henry Schein 8 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor MCK or MMSI?

In the previous week, McKesson had 25 more articles in the media than Merit Medical Systems. MarketBeat recorded 31 mentions for McKesson and 6 mentions for Merit Medical Systems. McKesson's average media sentiment score of 1.37 beat Merit Medical Systems' score of 0.94 indicating that McKesson is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 25 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Merit Medical Systems 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor MCK or AMN?

In the previous week, McKesson had 17 more articles in the media than AMN Healthcare Services. MarketBeat recorded 31 mentions for McKesson and 14 mentions for AMN Healthcare Services. McKesson's average media sentiment score of 1.37 beat AMN Healthcare Services' score of 0.17 indicating that McKesson is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 25 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AMN Healthcare Services 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

McKesson (MCK) Competitors

$737.98 +1.20 (+0.16%)

As of 12:46 PM Eastern

Compare

MCK vs. DXCM, HQY, HSIC, MMSI, and AMN

Should you buy McKesson stock or one of its competitors? MarketBeat compares McKesson with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with McKesson include DexCom (DXCM), HealthEquity (HQY), Henry Schein (HSIC), Merit Medical Systems (MMSI), and AMN Healthcare Services (AMN). These companies are all part of the "medical" sector.

How does McKesson compare to DexCom?

McKesson (NYSE:MCK) and DexCom (NASDAQ:DXCM) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability, media sentiment and analyst recommendations.

McKesson presently has a consensus price target of $968.87, suggesting a potential upside of 31.29%. DexCom has a consensus price target of $82.42, suggesting a potential upside of 13.13%. Given McKesson's higher possible upside, analysts plainly believe McKesson is more favorable than DexCom.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82
DexCom	1 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	3 Strong Buy rating(s)	2.92

85.1% of McKesson shares are owned by institutional investors. Comparatively, 97.8% of DexCom shares are owned by institutional investors. 0.1% of McKesson shares are owned by company insiders. Comparatively, 0.3% of DexCom shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

McKesson has a beta of 0.31, suggesting that its share price is 69% less volatile than the broader market. Comparatively, DexCom has a beta of 1.45, suggesting that its share price is 45% more volatile than the broader market.

In the previous week, McKesson had 9 more articles in the media than DexCom. MarketBeat recorded 31 mentions for McKesson and 22 mentions for DexCom. McKesson's average media sentiment score of 1.37 beat DexCom's score of 1.25 indicating that McKesson is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	25 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DexCom	20 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

McKesson has higher revenue and earnings than DexCom. McKesson is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.22	$4.76B	$38.47	19.18
DexCom	$4.82B	5.83	$836.30M	$2.34	31.13

DexCom has a net margin of 19.31% compared to McKesson's net margin of 1.18%. DexCom's return on equity of 33.33% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.18%	-345.35%	5.85%
DexCom	19.31%	33.33%	13.19%

Summary

DexCom beats McKesson on 11 of the 17 factors compared between the two stocks.

How does McKesson compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and McKesson (NYSE:MCK) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability.

McKesson has higher revenue and earnings than HealthEquity. McKesson is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	5.38	$215.20M	$2.67	31.64
McKesson	$403.43B	0.22	$4.76B	$38.47	19.18

HealthEquity has a beta of 0.21, meaning that its stock price is 79% less volatile than the broader market. Comparatively, McKesson has a beta of 0.31, meaning that its stock price is 69% less volatile than the broader market.

HealthEquity presently has a consensus target price of $111.53, indicating a potential upside of 32.02%. McKesson has a consensus target price of $968.87, indicating a potential upside of 31.29%. Given HealthEquity's stronger consensus rating and higher possible upside, analysts clearly believe HealthEquity is more favorable than McKesson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	1 Strong Buy rating(s)	2.87
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82

HealthEquity has a net margin of 17.25% compared to McKesson's net margin of 1.18%. HealthEquity's return on equity of 14.75% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.25%	14.75%	9.22%
McKesson	1.18%	-345.35%	5.85%

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 85.1% of McKesson shares are owned by institutional investors. 1.6% of HealthEquity shares are owned by insiders. Comparatively, 0.1% of McKesson shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, McKesson had 7 more articles in the media than HealthEquity. MarketBeat recorded 31 mentions for McKesson and 24 mentions for HealthEquity. McKesson's average media sentiment score of 1.37 beat HealthEquity's score of 0.59 indicating that McKesson is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	7 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
McKesson	25 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

HealthEquity beats McKesson on 10 of the 17 factors compared between the two stocks.

How does McKesson compare to Henry Schein?

McKesson (NYSE:MCK) and Henry Schein (NASDAQ:HSIC) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, media sentiment, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

85.1% of McKesson shares are held by institutional investors. Comparatively, 96.6% of Henry Schein shares are held by institutional investors. 0.1% of McKesson shares are held by company insiders. Comparatively, 0.9% of Henry Schein shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

McKesson has a beta of 0.31, meaning that its stock price is 69% less volatile than the broader market. Comparatively, Henry Schein has a beta of 0.82, meaning that its stock price is 18% less volatile than the broader market.

Henry Schein has a net margin of 2.95% compared to McKesson's net margin of 1.18%. Henry Schein's return on equity of 15.44% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.18%	-345.35%	5.85%
Henry Schein	2.95%	15.44%	5.53%

In the previous week, McKesson had 15 more articles in the media than Henry Schein. MarketBeat recorded 31 mentions for McKesson and 16 mentions for Henry Schein. McKesson's average media sentiment score of 1.37 beat Henry Schein's score of 0.77 indicating that McKesson is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	25 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Henry Schein	8 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

McKesson currently has a consensus target price of $968.87, suggesting a potential upside of 31.29%. Henry Schein has a consensus target price of $86.83, suggesting a potential upside of 14.56%. Given McKesson's stronger consensus rating and higher possible upside, research analysts clearly believe McKesson is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82
Henry Schein	1 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.36

McKesson has higher revenue and earnings than Henry Schein. McKesson is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.22	$4.76B	$38.47	19.18
Henry Schein	$13.18B	0.65	$398M	$3.31	22.90

Summary

McKesson beats Henry Schein on 9 of the 16 factors compared between the two stocks.

How does McKesson compare to Merit Medical Systems?

McKesson (NYSE:MCK) and Merit Medical Systems (NASDAQ:MMSI) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, media sentiment, dividends, risk, profitability and institutional ownership.

McKesson has a beta of 0.31, meaning that its share price is 69% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.54, meaning that its share price is 46% less volatile than the broader market.

McKesson has higher revenue and earnings than Merit Medical Systems. McKesson is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.22	$4.76B	$38.47	19.18
Merit Medical Systems	$1.52B	2.38	$128.49M	$2.31	26.19

Merit Medical Systems has a net margin of 9.03% compared to McKesson's net margin of 1.18%. Merit Medical Systems' return on equity of 13.54% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.18%	-345.35%	5.85%
Merit Medical Systems	9.03%	13.54%	7.94%

McKesson presently has a consensus price target of $968.87, indicating a potential upside of 31.29%. Merit Medical Systems has a consensus price target of $92.80, indicating a potential upside of 53.36%. Given Merit Medical Systems' higher possible upside, analysts clearly believe Merit Medical Systems is more favorable than McKesson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82
Merit Medical Systems	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64

In the previous week, McKesson had 25 more articles in the media than Merit Medical Systems. MarketBeat recorded 31 mentions for McKesson and 6 mentions for Merit Medical Systems. McKesson's average media sentiment score of 1.37 beat Merit Medical Systems' score of 0.94 indicating that McKesson is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	25 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Merit Medical Systems	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

85.1% of McKesson shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 0.1% of McKesson shares are owned by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Merit Medical Systems beats McKesson on 9 of the 16 factors compared between the two stocks.

How does McKesson compare to AMN Healthcare Services?

McKesson (NYSE:MCK) and AMN Healthcare Services (NYSE:AMN) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

McKesson pays an annual dividend of $3.28 per share and has a dividend yield of 0.4%. AMN Healthcare Services pays an annual dividend of $1.20 per share and has a dividend yield of 4.1%. McKesson pays out 8.5% of its earnings in the form of a dividend. AMN Healthcare Services pays out -137.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. McKesson has increased its dividend for 17 consecutive years. AMN Healthcare Services is clearly the better dividend stock, given its higher yield and lower payout ratio.

85.1% of McKesson shares are held by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are held by institutional investors. 0.1% of McKesson shares are held by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

McKesson has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.22	$4.76B	$38.47	19.18
AMN Healthcare Services	$3.42B	0.33	-$95.70M	-$0.87	N/A

In the previous week, McKesson had 17 more articles in the media than AMN Healthcare Services. MarketBeat recorded 31 mentions for McKesson and 14 mentions for AMN Healthcare Services. McKesson's average media sentiment score of 1.37 beat AMN Healthcare Services' score of 0.17 indicating that McKesson is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	25 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AMN Healthcare Services	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

McKesson has a beta of 0.31, indicating that its share price is 69% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.44, indicating that its share price is 56% less volatile than the broader market.

McKesson has a net margin of 1.18% compared to AMN Healthcare Services' net margin of -0.95%. AMN Healthcare Services' return on equity of 18.01% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.18%	-345.35%	5.85%
AMN Healthcare Services	-0.95%	18.01%	5.19%

McKesson currently has a consensus price target of $968.87, suggesting a potential upside of 31.29%. AMN Healthcare Services has a consensus price target of $25.29, suggesting a potential downside of 13.67%. Given McKesson's stronger consensus rating and higher possible upside, research analysts plainly believe McKesson is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22

Summary

McKesson beats AMN Healthcare Services on 12 of the 19 factors compared between the two stocks.

Get McKesson News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MCK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MCK vs. The Competition

Export

Metric	McKesson	MED/DENTAL Industry	Medical Sector	NYSE Exchange
Market Cap	$88.71B	$14.24B	$6.26B	$23.11B
Dividend Yield	0.45%	1.21%	2.69%	4.09%
P/E Ratio	19.18	17.16	22.37	31.03
Price / Sales	0.22	2.08	547.57	14.71
Price / Cash	16.12	13.42	42.31	24.78
Price / Book	-50.86	3.20	9.79	4.68
Net Income	$4.76B	$534.24M	$3.56B	$1.07B
7 Day Performance	-2.37%	-0.96%	-1.27%	-0.50%
1 Month Performance	-9.42%	5.09%	3.58%	0.39%
1 Year Performance	3.17%	-2.95%	27.13%	25.64%

McKesson Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MCK McKesson	4.9488 of 5 stars	$737.98 +0.2%	$968.87 +31.3%	+2.0%	$88.71B	$403.43B	19.18	43,000	Positive News Insider Trade
DXCM DexCom	4.4742 of 5 stars	$72.10 flat	$82.21 +14.0%	-14.1%	$27.82B	$4.82B	30.81	11,000	Positive News Analyst Forecast
HQY HealthEquity	4.3984 of 5 stars	$88.11 flat	$111.79 +26.9%	-14.1%	$7.39B	$1.31B	35.82	2,814	Earnings Report Analyst Forecast Insider Trade
HSIC Henry Schein	3.2715 of 5 stars	$74.21 flat	$86.83 +17.0%	+9.3%	$8.45B	$13.18B	22.42	25,000
MMSI Merit Medical Systems	4.7551 of 5 stars	$64.17 flat	$92.80 +44.6%	-35.0%	$3.83B	$1.52B	27.78	7,500

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MCK) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

McKesson (MCK) Competitors

MCK vs. DXCM, HQY, HSIC, MMSI, and AMN

How does McKesson compare to DexCom?

Summary

How does McKesson compare to HealthEquity?

Summary

How does McKesson compare to Henry Schein?

Summary

How does McKesson compare to Merit Medical Systems?

Summary

How does McKesson compare to AMN Healthcare Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MCK vs. The Competition

McKesson Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

McKesson (MCK) Competitors

MCK vs. DXCM, HQY, HSIC, MMSI, and AMN

How does McKesson compare to DexCom?

Do analysts recommend MCK or DXCM?

Do insiders & institutionals have more ownership in MCK or DXCM?

Which has more volatility & risk, MCK or DXCM?

Does the media prefer MCK or DXCM?

Which has better valuation & earnings, MCK or DXCM?

Is MCK or DXCM more profitable?

Summary

How does McKesson compare to HealthEquity?

Which has better earnings & valuation, HQY or MCK?

Which has more risk & volatility, HQY or MCK?

Do analysts rate HQY or MCK?

Is HQY or MCK more profitable?

Do insiders and institutionals believe in HQY or MCK?

Does the media prefer HQY or MCK?

Summary

How does McKesson compare to Henry Schein?

Do institutionals and insiders have more ownership in MCK or HSIC?

Which has more volatility & risk, MCK or HSIC?

Is MCK or HSIC more profitable?

Does the media favor MCK or HSIC?

Do analysts prefer MCK or HSIC?

Which has stronger earnings & valuation, MCK or HSIC?

Summary

How does McKesson compare to Merit Medical Systems?

Which has more volatility and risk, MCK or MMSI?

Which has higher earnings & valuation, MCK or MMSI?

Is MCK or MMSI more profitable?

Do analysts prefer MCK or MMSI?

Does the media favor MCK or MMSI?

Do institutionals & insiders hold more shares of MCK or MMSI?

Summary

How does McKesson compare to AMN Healthcare Services?

Is MCK or AMN a better dividend stock?

Do insiders & institutionals believe in MCK or AMN?

Which has better valuation and earnings, MCK or AMN?

Does the media favor MCK or AMN?

Which has more volatility and risk, MCK or AMN?

Is MCK or AMN more profitable?

Do analysts prefer MCK or AMN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MCK vs. The Competition

McKesson Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools